Personal Information
Organización/Lugar de trabajo
Kuala Lumpur, Malaysia
Ocupación
Frost & Sullivan
Etiquetas
xeraya capital
life sciences
coronavirus
covid-19
venture capital
esg
ai
crispr
private equity
biotechnology
healthcare
xerayacapital
circular economy
vaccines
fda
gene therapy
antibiotics
medical technology
gram negative bacteria
allecra
pharmaceutical
biomedical
sustainable financing
impact investing
renewable resources
green economy
glycoproteomics
emergency use authorization
mrna
vaccine
oxford
astrazeneca
clinical trial
vaccine production
mrna vaccine
mab
monoclonal antibodies
pandemic
machine learning
artificial intelligence
human microbiome
microbiome
adult leukemia
stem cells
drug approvals
talen
gene editing
genome
bacteria
liquidia
nanotechnology
3d printing
eric lefkofsky
elon musk
serial entrepreneurs
entrepreneurship
tobacco
smoking cessation
chrono therapeutics
plasma derivatives
preparative electrophoresis
chromatography
plasma separation
blood plasma
drug resistant bacteria
carbon offset
carbon credit
climate change
#carbon exchange
cannabis sativa
cbd
thc
cannabis legal status
pain control
cannabis pharma
medical marijuana
cannabis
gmo
nitrogen fixation
malnutrition
world hunger
food security
companion diagnostics
adenoma
tumor detection
cancer
analytes
non-invasive
biopsy
liquid biopsy
transplantation
sclerosis
diabetes
regenerative medicine
cord blood
progenitor cells
green investment
msci
sustainable investment
sustainable development
ri
sri
zfn
cancer immunotherapy
genome engineering
genome editing
augmented reality
virtual reality
telehealth
telemedicine
digital healthcare
digital health
renewable energy
specialty chemicals
renewable chemicals
high blood pressure
pah
pulmonary hypertension
pulmonary arterial hypertension
equity financing
raise capital
financing rounds
funding rounds
financing series
healthcare technology
deep learning
genomics analysis
rtificial intelligence
sovereign wealth fund
swf
rna technologies
vaccination
antiviral drugs
treatment
therapeutics
immunization
covid19
gene control
gene expression
epigenetic therapies
epigenetic pathways
epigenetics
biontech
pfizer
moderna
inclusive vaccines
iva
cepi
post marketing
drug discovery
nda
ind
animal testing
new drugs
drug testing
immunogenicity
vaccine manufacturing
immune response
b-cell
t-cell
recombinant vector vaccine
dna plasmid vaccine
herd immunity
vaccine platforms
rna drugs
immunomodulatory agents
cytokine release syndrome
cytokine storm
elisa
dna test
rna test
immunology assay
antibody assay
isothermal amplification
rt-pcr
diagnostics
socio economic impact
mortality rate
healthcare system
public policies
who
severe acute respiratory syndrome
sars
mers
diagnosis
bio ethanol
jet fuel
bio fuels
capture carbon
recycle carbon
lanzatech
corporate venture capital
cvc
google ventures
ge ventures
qualcomm ventures
health
microbiota
symbiosis
hospital acquired pneumonia
urinary tract infection
hospital acquired infections
medicine
bone marrow disease
blood disease
imago bio
oncomyx
acute myeloid leukemia
aml
socially responsible investment
responsible investment
governance
social
environment
bone marrow transplant
market study
cell therapy
novel drugs
drug therapy
cder
nonalcoholic fatty liver disease
nafld
nash
data analytics
data sharing
2019
trends
industry report
genetic engineering
zinc finger
cas9
medical devices
prime biologics
dna
rna
bacteria defense
crispr cas
bacteriophages
#xerayacapital
primebiologics
agriculture
industry
investment
medical
factsnfigures
innovation
Ver más
Presentaciones
(57)Documentos
(1)Personal Information
Organización/Lugar de trabajo
Kuala Lumpur, Malaysia
Ocupación
Frost & Sullivan
Etiquetas
xeraya capital
life sciences
coronavirus
covid-19
venture capital
esg
ai
crispr
private equity
biotechnology
healthcare
xerayacapital
circular economy
vaccines
fda
gene therapy
antibiotics
medical technology
gram negative bacteria
allecra
pharmaceutical
biomedical
sustainable financing
impact investing
renewable resources
green economy
glycoproteomics
emergency use authorization
mrna
vaccine
oxford
astrazeneca
clinical trial
vaccine production
mrna vaccine
mab
monoclonal antibodies
pandemic
machine learning
artificial intelligence
human microbiome
microbiome
adult leukemia
stem cells
drug approvals
talen
gene editing
genome
bacteria
liquidia
nanotechnology
3d printing
eric lefkofsky
elon musk
serial entrepreneurs
entrepreneurship
tobacco
smoking cessation
chrono therapeutics
plasma derivatives
preparative electrophoresis
chromatography
plasma separation
blood plasma
drug resistant bacteria
carbon offset
carbon credit
climate change
#carbon exchange
cannabis sativa
cbd
thc
cannabis legal status
pain control
cannabis pharma
medical marijuana
cannabis
gmo
nitrogen fixation
malnutrition
world hunger
food security
companion diagnostics
adenoma
tumor detection
cancer
analytes
non-invasive
biopsy
liquid biopsy
transplantation
sclerosis
diabetes
regenerative medicine
cord blood
progenitor cells
green investment
msci
sustainable investment
sustainable development
ri
sri
zfn
cancer immunotherapy
genome engineering
genome editing
augmented reality
virtual reality
telehealth
telemedicine
digital healthcare
digital health
renewable energy
specialty chemicals
renewable chemicals
high blood pressure
pah
pulmonary hypertension
pulmonary arterial hypertension
equity financing
raise capital
financing rounds
funding rounds
financing series
healthcare technology
deep learning
genomics analysis
rtificial intelligence
sovereign wealth fund
swf
rna technologies
vaccination
antiviral drugs
treatment
therapeutics
immunization
covid19
gene control
gene expression
epigenetic therapies
epigenetic pathways
epigenetics
biontech
pfizer
moderna
inclusive vaccines
iva
cepi
post marketing
drug discovery
nda
ind
animal testing
new drugs
drug testing
immunogenicity
vaccine manufacturing
immune response
b-cell
t-cell
recombinant vector vaccine
dna plasmid vaccine
herd immunity
vaccine platforms
rna drugs
immunomodulatory agents
cytokine release syndrome
cytokine storm
elisa
dna test
rna test
immunology assay
antibody assay
isothermal amplification
rt-pcr
diagnostics
socio economic impact
mortality rate
healthcare system
public policies
who
severe acute respiratory syndrome
sars
mers
diagnosis
bio ethanol
jet fuel
bio fuels
capture carbon
recycle carbon
lanzatech
corporate venture capital
cvc
google ventures
ge ventures
qualcomm ventures
health
microbiota
symbiosis
hospital acquired pneumonia
urinary tract infection
hospital acquired infections
medicine
bone marrow disease
blood disease
imago bio
oncomyx
acute myeloid leukemia
aml
socially responsible investment
responsible investment
governance
social
environment
bone marrow transplant
market study
cell therapy
novel drugs
drug therapy
cder
nonalcoholic fatty liver disease
nafld
nash
data analytics
data sharing
2019
trends
industry report
genetic engineering
zinc finger
cas9
medical devices
prime biologics
dna
rna
bacteria defense
crispr cas
bacteriophages
#xerayacapital
primebiologics
agriculture
industry
investment
medical
factsnfigures
innovation
Ver más